Elanco Animal Health (ELAN) Gross Profit (2017 - 2026)

Elanco Animal Health has disclosed Gross Profit across 10 years of filings, most recently posting $798.0 million for Q2 2026.

• In Q2 2026, Gross Profit rose 11.92% year-over-year to $798.0 million; the TTM figure through Jun 2026 stood at $2.8 billion (up 13.24% YoY), while the FY2025 annual figure was $2.6 billion, up 6.44% from the prior year.
• Gross Profit came in at $798.0 million for Q2 2026 at Elanco Animal Health, up from $785.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $798.0 million in Q2 2026 to a low of $519.0 million in Q4 2023.
• Average Gross Profit over 5 years is $644.3 million, with a median of $653.5 million recorded in 2023.
• Year-over-year, Gross Profit retreated 11.92% in 2022 and climbed 14.77% in 2026.
• Over 5 years, Gross Profit stood at $537.0 million in 2022, then dropped by 3.35% to $519.0 million in 2023, then changed by 0.0% to $519.0 million in 2024, then advanced by 13.49% to $589.0 million in 2025, then jumped by 35.48% to $798.0 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $798.0 million in Q2 2026, $785.0 million in Q1 2026, and $589.0 million in Q4 2025.